BU
BURUW
Nuburu, Inc.
No data for this timeframe.
Vol
Market Cap$29.1M
Cap SizeNano Cap
SEC Reports6
Recent Activity
Jun 9, 2026
SEC
Nuburu entered a binding Head of Terms with Italian laser-tech developer SunCubes to form an industrial cooperation fram
8-K — Impact 5/10
May 15, 2026
SEC
Nuburu, Inc. received a second NYSE American delisting notice on May 12, 2026, for failing to maintain $4.0M in stockhol
8-K — Impact 8/10
May 13, 2026
SEC
Nuburu's S-3 shelf registration (File No. 333-295324) became effective on May 12, 2026, enabling the company to sell up
EFFECT — Impact 6/10
Latest Reports
NEUTRAL
8-K
5/10
Nuburu entered a binding Head of Terms with Italian laser-tech developer SunCubes to form an industrial cooperation fram
Jun 9, 2026
BEARISH
8-K
8/10
Nuburu, Inc. received a second NYSE American delisting notice on May 12, 2026, for failing to maintain $4.0M in stockhol
May 15, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 4 bearish, 0 mixed, 2 neutral. Avg impact: 5.8/10.
NEUTRAL
8-K
5/10
Nuburu entered a binding Head of Terms with Italian laser-tech developer SunCubes to form an industr
Jun 9, 2026
BEARISH
8-K
8/10
Nuburu, Inc. received a second NYSE American delisting notice on May 12, 2026, for failing to mainta
May 15, 2026
BEARISH
EFFECT
6/10
Nuburu's S-3 shelf registration (File No. 333-295324) became effective on May 12, 2026, enabling the
May 13, 2026
BEARISH
S-3/A
6/10
Nuburu, Inc. filed an S-3/A registration statement to register up to 60,000,000 shares of common sto
May 7, 2026
NEUTRAL
10-K/A
4/10
Nuburu filed Amendment No. 1 to its 2025 Form 10-K solely to add Part III information (directors, ex
Apr 28, 2026
BEARISH
S-3
6/10
Nuburu, Inc. has filed an S-3 shelf registration to register up to 60 million shares of common stock
Apr 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.